Skip to main content

Advertisement

SpringerLink
Log in

Severe spontaneous epistaxis: retrospective study in a tertiary ENT centre

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the clinical profile and outcomes of different treatment strategies in patients hospitalized for spontaneous severe epistaxis.

Methods

This is a retrospective descriptive study of a case series of patients hospitalized for epistaxis in the University Hospital of Ghent between 2005 and 2012.

Results

124 patients with, respectively, 132 episodes were included. 64% were male. The mean age was 65 years. 73% had comorbidities of which arterial hypertension was the most common. 61% were taking one or more antithrombotics and in 25.7% a recent change in the medication schedule took place. 47% of the episodes necessitated a vascular intervention. The most performed surgery was endoscopic sphenopalatine artery ligation. The 1-year success rate of conservative treatment was 47% and of vascular intervention 81%. No significant difference between the recurrence rates and need for vascular intervention of the different comorbidities and medications was detected using Pearson chi-squared and Fisher’s exact testing. The overall 5-year survival rate was 83.6%.

Conclusions

The typical pattern of a patient presenting with severe epistaxis was a patient in the sixth decade, male, suffering from comorbidities and taking one or more antithrombotic agents. Based on the above-mentioned success rates of the different treatment options, we think all centres treating epistaxis should apply a well-defined protocol to guide the decision when to proceed with surgery. Furthermore, prospective research needs to precisely investigate the role played by comorbidities and their treatment in the occurrence of epistaxis and to test the effectiveness of proposed algorithms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Choudhury N, Sharp HR, Mir N, Salama NY (2004) Epistaxis and oral anticoagulant therapy. Rhinology 42(2):92–97

    CAS  PubMed  Google Scholar 

  2. Viehweg TL, Roberson JB, Hudson JW (2006) Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg 64(3):511–518

    Article  PubMed  Google Scholar 

  3. Upile T, Jerjes W, Sipaul F, Maaytah ME, Singh S, Hopper C et al (2008) A change in UK epistaxis management. Eur Arch Oto-rhino-laryngol 265(11):1349–1354

    Article  Google Scholar 

  4. Saraceni Neto P, Nunes LM, Gregorio LC, Santos Rde P, Kosugi EM (2013) Surgical treatment of severe epistaxis: an 11-year experience. Braz J Otorhinolaryngol 79(1):59–64

    Article  PubMed  Google Scholar 

  5. Spielmann PM, Barnes ML, White PS (2012) Controversies in the specialist management of adult epistaxis: an evidence-based review. Clin Otolaryngol 37(5):382–389

    Article  CAS  PubMed  Google Scholar 

  6. Melia L, McGarry GW (2011) Epistaxis: update on management. Curr Opin Otolaryngol Head Neck Surg 19(1):30–35

    Article  PubMed  Google Scholar 

  7. Monjas-Cánovas I, Hernández-García I, Mauri-Barberá J, Sanz-Romero B, Gras-Albert J (2010) Epidemiology of epistaxis admitted to a tertiary hospital. Acta Otorrinolaringol Espanola 61(1):41–47

    Article  Google Scholar 

  8. Pallin DJ, Chng YM, McKay MP, Emond JA, Pelletier AJ, Camargo CA Jr (2005) Epidemiology of epistaxis in US emergency departments, 1992–2001. Ann Emerg Med 46(1):77–81

    Article  PubMed  Google Scholar 

  9. Fishpool SJ, Tomkinson A (2012) Patterns of hospital admission with epistaxis for 26,725 patients over an 18-year period in Wales, UK. Ann R Coll Surg Engl 94(8):559–562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Manfredini R, Portaluppi F, Salmi R, Martini A, Gallerani M (2000) Circadian variation in onset of epistaxis: analysis of hospital admissions. BMJ 321(7269):1112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Manes RP (2010) Evaluating and managing the patient with nosebleeds. Med Clin N Am 94(5):903–912

    Article  PubMed  Google Scholar 

  12. Herkner H, Laggner AN, Mullner M, Formanek M, Bur A, Gamper G et al (2000) Hypertension in patients presenting with epistaxis. Ann Emerg Med 35(2):126–130

    Article  CAS  PubMed  Google Scholar 

  13. Herkner H, Havel C, Mullner M, Gamper G, Bur A, Temmel AF et al (2002) Active epistaxis at ED presentation is associated with arterial hypertension. Am J Emerg Med 20(2):92–95

    Article  PubMed  Google Scholar 

  14. Fagard RH (2002) Epidemiology of hypertension in the elderly. Am J Geriatric Cardiol 11(1):23–28

    Article  Google Scholar 

  15. Soyka MB, Rufibach K, Huber A, Holzmann D (2010) Is severe epistaxis associated with acetylsalicylic acid intake? Laryngoscope 120(1):200–207

    PubMed  Google Scholar 

  16. Rainsbury JW, Molony NC (2009) Clopidogrel versus low-dose aspirin as risk factors for epistaxis. Clin Otolaryngol 34(3):232–325

    Article  CAS  PubMed  Google Scholar 

  17. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D’Angelo A et al (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on complications of oral anticoagulant therapy. Lancet 348(9025):423–428

    Article  CAS  PubMed  Google Scholar 

  18. Mekaj YH, Mekaj AY, Duci SB, Miftari EI (2015) New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Therapeutics Clin Risk Manag 11:967–977

    Article  CAS  Google Scholar 

  19. Rivera CA, Ferro CL, Bursua AJ, Gerber BS (2012) Probable interaction between Lycium barbarum (goji) and warfarin. Pharmacotherapy 32(3):e50–e53

    Article  PubMed  Google Scholar 

  20. Mowla A, Dastgheib SA, Ebrahimi AA, Pani A (2009) Nasal bleeding associated with fluoxetine and risperidone interaction: a case report. Pharmacopsychiatry 42(5):204–205

    Article  CAS  PubMed  Google Scholar 

  21. Yildirim Y, Ozyilkan O, Akcali Z, Basturk B (2006) Drug interaction between capecitabine and warfarin: a case report and review of the literature. Int J Clin Pharmacol Therapeutics 44(2):80–82

    Article  CAS  Google Scholar 

  22. Nisa L, Nicoucar K, Giger R (2013) Major bleeding of the upper aerodigestive tract due to oral anticoagulant/antibiotic interactions. Eur Ann Otorhinolaryngol Head Neck Dis 130(3):153–156

    Article  CAS  PubMed  Google Scholar 

  23. Badran K, Malik TH, Belloso A, Timms MS (2005) Randomized controlled trial comparing Merocel and RapidRhino packing in the management of anterior epistaxis. Clin Otolaryngol 30(4):333–337

    Article  CAS  PubMed  Google Scholar 

  24. Abdelkader M, Leong SC, White PS (2007) Endoscopic control of the sphenopalatine artery for epistaxis: long-term results. J Laryngol Otol 121(8):759–762

    Article  CAS  PubMed  Google Scholar 

  25. Schaitkin B, Strauss M, Houck JR (1987) Epistaxis: medical versus surgical therapy: a comparison of efficacy, complications, and economic considerations. Laryngoscope 97(12):1392–1396

    Article  CAS  PubMed  Google Scholar 

  26. Shaw CB, Wax MK, Wetmore SJ (1993) Epistaxis: a comparison of treatment. Otolaryngol Head Neck Surg 109(1):60–65

    Article  CAS  PubMed  Google Scholar 

  27. Soyka MB, Nikolaou G, Rufibach K, Holzmann D (2011) On the effectiveness of treatment options in epistaxis: an analysis of 678 interventions. Rhinology 49(4):474–478

    CAS  PubMed  Google Scholar 

  28. Rudmik L, Leung R (2014) Cost-effectiveness analysis of endoscopic sphenopalatine artery ligation vs arterial embolization for intractable epistaxis. JAMA Otolaryngol Head Neck Surg 140(9):802–808

    Article  PubMed  Google Scholar 

  29. Floreani SR, Nair SB, Switajewski MC, Wormald PJ (2006) Endoscopic anterior ethmoidal artery ligation: a cadaver study. Laryngoscope 116(7):1263–1267

    Article  PubMed  Google Scholar 

  30. Feusi B, Holzmann D, Steurer J (2005) Posterior epistaxis: systematic review on the effectiveness of surgical therapies. Rhinology 43(4):300–304

    PubMed  Google Scholar 

  31. Nouraei SA, Maani T, Hajioff D, Saleh HA, Mackay IS (2007) Outcome of endoscopic sphenopalatine artery occlusion for intractable epistaxis: a 10-year experience. Laryngoscope 117(8):1452–1456

    Article  PubMed  Google Scholar 

  32. Kumar S, Shetty A, Rockey J, Nilssen E (2003) Contemporary surgical treatment of epistaxis. What is the evidence for sphenopalatine artery ligation? Clin Otolaryngol Allied Sci 28(4):360–363

    Article  CAS  PubMed  Google Scholar 

  33. Moshaver A, Harris JR, Liu R, Diamond C, Seikaly H (2004) Early operative intervention versus conventional treatment in epistaxis: randomized prospective trial. J Otolaryngol 33(3):185–188

    Article  PubMed  Google Scholar 

  34. Dedhia RC, Desai SS, Smith KJ, Lee S, Schaitkin BM, Snyderman CH et al (2013) Cost-effectiveness of endoscopic sphenopalatine artery ligation versus nasal packing as first-line treatment for posterior epistaxis. Int Forum Allergy Rhinol 3(7):563–566

    Article  PubMed  Google Scholar 

  35. Loughran S, Hilmi O, McGarry GW (2005) Endoscopic sphenopalatine artery ligation—when, why and how to do it. An on-line video tutorial. Clin Otolaryngol 30(6):539–543

    Article  CAS  PubMed  Google Scholar 

  36. Barnes ML, Spielmann PM, White PS (2012) Epistaxis: a contemporary evidence based approach. Otolaryngol Clin N Am 45(5):1005–1017

    Article  CAS  Google Scholar 

  37. Murer K, Ahmad N, Roth BA, Holzmann D, Soyka MB (2013) THREAT helps to identify epistaxis patients requiring blood transfusions. J Otolaryngol Head Neck Surg 42:4

    Article  PubMed  PubMed Central  Google Scholar 

  38. Eikelboom JHJ (2006) Bleeding and management of bleeding. Eur Heart J Suppl 8(supplement G):G38–G45

    Article  Google Scholar 

  39. Rao SV, O’Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW et al (2006) A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 47(4):809–816

    Article  PubMed  Google Scholar 

  40. Rao SV, O’Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F et al (2005) Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 96(9):1200–1206

    Article  PubMed  Google Scholar 

  41. Yang X, Alexander KP, Chen AY, Roe MT, Brindis RG, Rao SV et al (2005) The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46(8):1490–1495

    Article  PubMed  Google Scholar 

  42. Moscucci M, Fox KA, Cannon CP, Klein W, Lopez-Sendon J, Montalescot G et al (2003) Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24(20):1815–1823

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Financial disclosure of authors: none reported.

Author information

Authors and Affiliations

  1. Department of Otolaryngology, University Hospital of Ghent, Corneel Heymanslaan 10, 9000, Ghent, Belgium

    Eline Marin, Jean-Baptiste Watelet, Philippe Gevaert & Thibaut Van Zele

Authors
  1. Eline Marin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Baptiste Watelet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philippe Gevaert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thibaut Van Zele
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ME: data collection, data analysis, drafting and revising the manuscript. WJ-B: design of the research project, revising the manuscript, treating physician of the patients included in the study. GP: revising the manuscript, treating physician of the patients included in the study. VZT: design of the research project, revising the manuscript, treating physician of the patients included in the study.

Corresponding author

Correspondence to Eline Marin.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marin, E., Watelet, JB., Gevaert, P. et al. Severe spontaneous epistaxis: retrospective study in a tertiary ENT centre. Eur Arch Otorhinolaryngol 276, 1693–1699 (2019). https://doi.org/10.1007/s00405-019-05392-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-019-05392-x

Keywords

Search

Navigation